Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangping Wu

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Molecular Cancer|May 22, 2026
CTHRC1 drives megakaryocyte-mediated immunotherapy resistance in esophageal squamous cell carcinoma via the integrin αIIbβ3/Rap1 pathway and is targetable by mRNA vaccinationYixin Liu, Jianfeng Zhou, Mengyuan Song, et al.
Nature Biomedical Engineering|December 7, 2021
Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapyKewen Lei, Armand Kurum, Murat Kaynak, et al.
Frontiers in Cell and Developmental Biology|July 26, 2021
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal CarcinomaYuyin Fu, Yujia Peng, Shengyan Zhao, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Therapeutic potential of an anti-HER2 single chain antibody-DM1 conjugates for the treatment of HER2-positive cancerHang Zhang, Yuxi Wang, Yangping Wu, et al.
American Journal of Cancer Research|May 9, 2018
A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft modelsRuixue Wang, Qinhuai Lai, Liangze Tang, et al.
Molecular Oncology|May 23, 2019
Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinomaYiran Tao, Ruixue Wang, Qinhuai Lai, et al.
Blood|October 6, 2023
Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemiaJingliao Zhang, Yongjuan Duan, Peng Wu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular Cancer|May 22, 2026
CTHRC1 drives megakaryocyte-mediated immunotherapy resistance in esophageal squamous cell carcinoma via the integrin αIIbβ3/Rap1 pathway and is targetable by mRNA vaccinationYixin Liu, Jianfeng Zhou, Mengyuan Song, et al.
Nature Biomedical Engineering|December 7, 2021
Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapyKewen Lei, Armand Kurum, Murat Kaynak, et al.
Frontiers in Cell and Developmental Biology|July 26, 2021
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal CarcinomaYuyin Fu, Yujia Peng, Shengyan Zhao, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Therapeutic potential of an anti-HER2 single chain antibody-DM1 conjugates for the treatment of HER2-positive cancerHang Zhang, Yuxi Wang, Yangping Wu, et al.
American Journal of Cancer Research|May 9, 2018
A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft modelsRuixue Wang, Qinhuai Lai, Liangze Tang, et al.
Molecular Oncology|May 23, 2019
Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinomaYiran Tao, Ruixue Wang, Qinhuai Lai, et al.
Blood|October 6, 2023
Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemiaJingliao Zhang, Yongjuan Duan, Peng Wu, et al.
Pageof 4